Gene and cell therapy firm Oxford Biomedica is to invest £4 million to build digital and robotics capabilities that will help manufacture the next generation of cutting edge therapies.
The UK’s government is urging businesses to apply for a share of up to £1.5 million to support real-world testing of medical devices and digital technology that could make the NHS more effi